Document Detail


White clot syndrome.
MedLine Citation:
PMID:  3368814     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Heparin therapy is currently a vital component in the medical management of thromboembolic events. Despite its widespread use, it is associated with relatively few complications, and these are usually minor and quickly reversible. Recently a much more dramatic and serious complication of heparin therapy has been identified. In heparin-induced thrombocytopenia with associated thrombosis or "white clot syndrome," patients have paradoxic thromboembolic events while receiving heparin. These events are of acute onset and of major consequence, often resulting in limb loss or death. This paper describes our own experience with ten patients in whom the white clot syndrome occurred during heparin therapy for thrombotic or embolic events. Both porcine and bovine heparin preparations were being given through various routes. In the three cases in which platelet aggregation testing was completed, results were positive. Our ten patients ultimately had a 20% major limb amputation rate and an overall 50% mortality.
Authors:
P E Stanton; J R Evans; A A Lefemine; N M Vo; G A Rannick; C V Morgan; P J Hinton; M Read
Related Documents :
17723124 - Efficacy of inferior vena cava filters in anticoagulated patients.
1939334 - The vena tech filter: evaluation of a new inferior vena cava interruption device.
7375824 - Postoperative deep venous thrombosis and infectious complications. a clinical study of ...
9684804 - Is plasminogen deficiency a thrombotic risk factor? a study on 23 thrombophilic patient...
11239224 - Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing hpc...
23408844 - Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodi...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Southern medical journal     Volume:  81     ISSN:  0038-4348     ISO Abbreviation:  South. Med. J.     Publication Date:  1988 May 
Date Detail:
Created Date:  1988-06-15     Completed Date:  1988-06-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0404522     Medline TA:  South Med J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  616-20     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Quillen-Dishner College of Medicine, East Tennessee State University, Johnson City 37614.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Female
Heparin / adverse effects*
Humans
Middle Aged
Platelet Aggregation / drug effects
Platelet Count
Syndrome
Thrombocytopenia / blood,  chemically induced*,  diagnosis
Thrombosis / blood,  chemically induced*,  diagnosis
Chemical
Reg. No./Substance:
9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alternatives in the treatment of hemorrhoidal disease.
Next Document:  Creating risk-sensitive persons: the roles of choice and chance in staying healthy.